Article info

Download PDFPDF

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial
Free
  1. Correspondence to:
    Dr E C Creutzberg
    University Hospital Maastricht, Department of Respiratory Medicine, P O Box 5800, 6202 AZ Maastricht, The Netherlands; evacreutzbergproteion.nl
View Full Text

Citation

Wouters EFM, Postma DS, Fokkens B, et al
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

Publication history

  • Received September 14, 2004
  • Accepted February 23, 2005
  • First published May 27, 2005.
Online issue publication 
May 27, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.